Objectives: To define, for the C5.18 chondrocyte-restricted rat cell line, (1) the capacities for recognition of alternatively spliced segments of the adhesion protein fibronectin (FN), (2) the integrin subunits required for such recognition, and (3) differences in such FN recognition vs the multipotential chondroprogenitor line, RCJ 3.1.
Introduction
The molecular composition of the extracellular matrix (ECM) in chondrogenic tissues varies across embryonic development, potentially providing signals for cells to proceed through specific phases of differentiation. Included among such components are members of the fibronectin (FN) family of adhesion proteins 1e5 . Although encoded by a single gene, FN pre-messenger RNA (mRNA) is subject to alternative splicing at three sites, corresponding with the extra type III repeat B (EIIIB), extra type III repeat A (EIIIA) and V segments (Fig. 1) . The former two of these are w90 amino acid type III repeat structures, which may either be wholly included or excluded. In contrast, the V region does not conform with a repeating module and is subject to partial or total inclusion 6, 7 . The finding that soluble FN fragments regulate chondrocyte gene expression, whereas full-length FN does not, indicates that FN structure is critical to its interactions with chondrocytes 8e11 , and reinforces the concept that alternative splicing could regulate FNechondrocyte interactions. While all three spliced segments of FN are widely co-expressed in the early embryo, EIIIA expression ceases in precartilaginous cell condensations near the time of chondrogenesis 4, 5 . Cartilage is also the only tissue in which splicing can exclude the V segment together with the adjacent 15th type III and 10th type I repeats, accounting for w80% of FNs in mature cartilage 6, 12 . To test the hypothesis that the ''cartilage-restricted'' EIIIA and/or V segments could be poorly compatible with differentiated chondrocyte function or cartilage matrix structure in vitro will require systems in which these segments are recognized by cells that are subject to chondrocytic differentiation, and for which the conditions for such recognition have been established.
A potential barrier to the development of cell-based systems to study chondrocyte differentiation and chondrogenesis is that differentiated and terminally differentiated chondrocyte phenotypes are unstable in vitro. An exception to this rule is the nontransformed chondrocyte-restricted rat cell line RCJ 3.1C5.18 (C5.18), which expresses differentiated and terminally differentiated chondrocyte phenotypes in a sequence that mimics chondrocytes in the endochondral growth plate 13, 14 . Therefore, the C5.18 line potentially constitutes a system with which to examine the effects of FN splicing on chondrocyte gene expression and differentiation. We have used cell adhesion assays to determine that C5.18 cells recognize the EIIIA and V, but not EIIIB, segments of FN. Despite a relative lack of chondrocyte-specific gene expression, the RCJ 3.1 multipotential chondroprogenitor cell line from which C5.18 cells were originally derived exhibited FN recognition that was generally similar to C5.18 cells, suggesting that acquisition of such gene expression may not be tightly associated with a cell's capacity to recognize specific FN structural moieties.
Methods

CELL CULTURE
C5. 18 and RCJ3.1 cell lines were cultured in monolayer, passaged, and replated as described 15 except that dexamethasone and ascorbic acid were not added to RCJ3.1 medium. Following proteolytic release, cell suspensions were washed with 0.5 mg/ml soy bean trypsin inhibitor (Sigma) and counted in serum-free alpha-MEM þ 1% bovine serum albumin (BSA) prior to cell adhesion assays.
SYNTHETIC PEPTIDES, FUSION PROTEINS, AND RAT PLASMA FN (pFN)
Glycine-arginine-glycine-aspartic acid-serine-proline (GRGDSP) and glycine-arginine-glycine-glutamic acid-serine-proline (GRGESP) with high performance liquid chromatography (HPLC) purity > 98% were purchased from Anaspec Inc., San Jose, CA. EILDV (HPLC purity >97%) was from Bachem, Torrance, CA. EIIIB-GST, EIIIA-GST, III-10-GST, V-GST and GST fusion proteins, each containing an N-terminal GST, were cloned, sequenced, expressed, and purified as described 5, 16 . Recombinant III7-15 partial FNs, containing one or no spliced segments, and with or without deletion of the RGD sequence in III-10 17 ( Fig. 1) were cloned as described 18 and generously provided as glycerol stocks by Richard Hynes of M.I.T, Cambridge, MA. All constructs were doubly purified via sequential histidine (his) followed by GST-tag affinity isolation as described 18 , except that the imidazole concentration for elution of the Ni-NTA agarose (Qiagen, Valencia, CA) column was 250 mM. Proteins were quantitated using bicinchoninic acid (BCA) reagent (Pierce, Rockford, Il) and purity and spliced segment content was confirmed by sodium dodecyl sulfate (SDS)-PAGE and western immunoblot analysis using rabbit antisera to EIIIB-maltose-binding protein or to V95 subsegment fusion protein to detect the EIIIB and V segments respectively, or MAb 15/27 to detect EIIIA 5, 16 . Rat pFN was from GIBCO/ BRL (Grand Island, NY). Proteins and peptides were stored in aliquots at À75 C prior to use. , and 1000 nM. ELISAs were performed either with anti-GST (left panels, data represent the average of 4 assays) or anti-his (right panels, average of three assays) antibodies to detect plastic-bound III7-15 constructs (doubly tagged with N-terminal GST and C-terminal his), whereas only anti-GST antibodies were used for FN segments, each of which contained single N-terminal GST tag. Note that increasing protein coating concentrations are associated with increases in optical density signals for each recombinant FN and for GST as detected by an anti-GST antibody, but not for phosphate-buffered saline (PBS , and HM a5-1 (a 5 ). MAb 15/27 was raised to a 29 amino acid peptide from the center of the human EIIIA segment as described 16 . The EIIIA-specific MAb IST-9 was from Abcam, Cambridge, MA.
CELL ADHESION ASSAYS
Fusion proteins or pFN were diluted in PBS, pH 7.4, and 50 ml aliquots were incubated in microtiter wells in triplicate for 2 h at 37 C or overnight at 4 C. After washing twice with PBS, wells were blocked with 1% BSA in PBS for 1 h at 37 C. After washing again in PBS, 75 ml aliquots of single cell suspensions at 1.33 Â 10 6 /ml in Hepes buffer (10 mM Hepes, 150 mM NaCl, 0.25% BSA, and 2 mM glucose) with or without divalent cations, were added to the wells containing equal volumes of the same medium with or without inhibitors. After 2 h at 37 C, wells were washed three times with appropriate Hepes buffer and adherent cells quantified by adding 100 ml of substrate/lysis solution to each well: 1% Triton X-100 (Fisher Scientific, Pittsburg, PA), 6 mg/ml p-nitrophenylphosphate (PNPP) (Sigma), in 50 mM sodium acetate buffer, pH 5.0. After 45 min at 37 C, the reaction was terminated with 50 ml of 1 M NaOH, and read at 405 nm in a microtiter plate reader (Tecan, Mannedorf, Switzerland). Adherence was expressed as a percentage of cells originally added to each well, determined from a standard curve generated using known numbers of cells. Absorbance readings from blank wells were averaged and subtracted from readings obtained in sample wells to subtract background.
REAL-TIME POLYMERASE CHAIN REACTION (PCR)
Reagents and apparatuses were from Applied Biosystems, Foster City, CA, unless indicated otherwise. 5 Â 10 5 e2 Â 10 6 cells were added to 500 ml 1X nucleic acid purification lysis buffer, then homogenized in a GenoGrinder 2000 (SpexCertiprep, Metuchen, NJ) after the addition of proteinase K (Invitrogen, Carlsbad, CA). Total ribonucleic acid (RNA) was extracted using a 6100 Nucleic Acid PrepStation and coding DNA (cDNA) was synthesized using the Quantitect Reverse Transcription kit (Qiagen). 1 ml of digested total RNA was Real-time PCR analyzed with rat glyceraldehyde phosphate dehydrogenase (rGAPDH) to confirm digestion of all genomic DNA. Rat TaqMan Ò Gene Expression assays were used for type 1 collagen (Rn00801649_g1), type 2 collagen (Rn00563954_m1), aggrecan (Rn00573424_m1), and rGAPDH (Rn99999916_s1). The assay for link protein (rCrtl1) was designed using Primer Express 3 by the Lucy Whittier Molecular and Diagnostic Core facility with the sequence from the listed genebank accession number X55057 20 . Each PCR reaction contained primers at 400 nM, TaqMan Ò probe at 80 nM, and Universal PCR Mastermix. The default cycling conditions were used for the AB PRISM 7900 HT FAST Real-Time PCR System. Ct values were exported with a threshold of 0.1 and a baseline of 3e12 for the genes of interest and Gapdh.
ENZYME LINKED IMMUNOSORBENT ASSAYS (ELISAs)
These were performed as described 16 using alkaline phosphatase-conjugated anti-GST (Sigma) or anti-his (Abcam) antibodies.
ANALYSIS OF DOSE-RESPONSE CURVES
Curves depicting cell adhesion across varying concentrations of coating protein were analyzed with the Ligand Binding macro in SigmaPlot 10.0 (Sigma), using the sigmoidal dose-response equation, for: (1) the concentration at which 50% of maximal cell adherence signal was attained (''excitatory concentration 50%'' or ''EC50''), and (2) the % of applied cells that became adherent at the maximal protein coating concentration tested (''maximum % adhesion'' or ''Max%A''). Curves representing the optical density (OD) response to coating protein in ELISAs were similarly analyzed for the concentration at which 50% of maximal OD was achieved. EC50s were calculated only for curves for which a sigmoid ''shoulder'' could be visualized at maximum protein coating concentrations.
STATISTICS
Data are presented as the average AE standard deviation. Statistical analyses were performed with GraphPad Prism 4.0 (GraphPad Software, San Diego, CA). Differences between two means were assessed by unpaired, two-tailed Student's t tests, except for the real-time PCR data, which was analyzed using one-tailed paired t tests. Differences among multiple means were assessed by one-way analysis of variance, followed by Tukey's post hoc test.
Results
C5.18 CELLS EXHIBIT INCREASED CHONDROCYTE-SPECIFIC GENE EXPRESSION IN COMPARISON TO RCJ 3.1 CELLS
Real-time PCR was used to compare gene expression in C5.18 and RCJ 3.1 cells that had been grown to confluency over 7 days. The C5.18 cell line exhibited significantly greater expression of mRNA for the chondrocyte-specific genes encoding type 2 collagen and aggrecan, but not type 1 collagen (Table I ). Link protein expression was also greater in C5.18 than RCJ 3.1 cells, but the difference did not attain significance (P ¼ 0.08). . In contrast, III-10-GST, EIIIA-GST, and V-GST each promoted cationdependent cell adhesion that was significantly greater than observed on surfaces coated with GST. For example, in 1 mM calcium plus 1 mM magnesium (Ca/Mg), each cell line exhibited adhesion to either III-10-GST or to V-GST that was significantly greater than for GST. Both cell lines also exhibited significant adherence to III-10 and V in the presence of manganese (Mn), but with Mn concentration thresholds that differed between the two segments and two cell lines [ Fig. 2 (panel A)] . In contrast, adhesion significantly exceeding GST did not occur on EIIIA-GST in Ca/ Mg, although the percent of cells that became adherent was significantly greater for RCJ 3.1 than C5.18 cells (16.1 AE 5.6% vs 2.3 AE 1.1%, respectively, P < 0.05) *C5.18 and RCJ 3.1 cells were grown to confluence over 7 days in monolayer cultures, after which cell RNA was harvested and subjected to reverse transcriptase cDNA synthesis, followed by q PCR. Expression of three chondrocyte-specific genes (type 2 collagen, aggrecan, and link protein) and one non-chondrocyte-specific gene (type 1 collagen) were analyzed. To determine changes in mRNA levels of targeted genes across multiple samples, the relative quantification method was used. The results, representing four experiments, are reported as the relative transcription (n-fold difference) of each target gene for C5. 18 (from left to right) EIIIB, III-10, EIIIA, and V, each at 180 nM, which promoted >90% of maximal cell adhesion for III-10-GST, EIIIA-GST, and V-GST (see Fig. 3 ). C5.18 (top panels) or RCJ 3.1 (bottom panels) cells were then added to wells in the presence of adhesion buffer containing no cations, 1 mM Ca plus 1 mM Mg (Ca/Mg), or Mn at 10, 50 or 100 mM, as described in Methods. Fig. 2 (panel A)] . Nevertheless, each line adhered to EIIIA in Mn, with C5.18 cells attaining significant adhesion at 50 mM and RCJ 3.1 cells at 100 mM. The preferential adhesion of cells to GST fusion proteins bearing FN segments was not attributable to increased adsorbance of these proteins to microtiter wells in comparison to GST, since ELISA using anti-GST antibodies suggested greater absorption of isolated GST per applied mole than the other proteins (Fig. 1) . Also, both cell lines adhered to his-tagged isolated III-10 and EIIIA segments with similar cation dependency profiles to those shown here for III-10-GST and EIIIA-GST (data not shown). Fig. 3 . C5.18 and RCJ 3.1 cell lines both exhibit differences in adhesion to pFN in comparison to isolated segments of FN. Microtiter wells were coated with dilution series of GST, EIIIB-GST, III-10-GST, EIIIA-GST, V-GST or rat pFN, and the percent of cells applied that became adherent was measured. For both cell lines, pFN promoted cell adhesion at lower coating concentrations than the isolated FN segments (also see Table II ). Additionally, C5.18 cell adhesion to pFN-coated surfaces was similar in the presence of Ca/Mg as compared to Mn, whereas adhesion to III-10, EIIIA, and V segments occurred at lower coating concentrations in Mn as compared to Ca/Mg. Results were averaged for three experiments, each of which was performed with triplicate wells for each condition. *Cell adhesion was measured in the presence of Ca/Mg or Mn in microtiter wells coated with dilution series of different GST fusion proteins or rat (pFN) and the resulting dose-response curves were analyzed for: (1) EC50 ¼ the coating concentration at which 50% of maximal cell adhesion was attained, and (2) Max%A ¼ the maximum percentage of cells applied that became adherent. ''e'' indicates that the dose-response curve was not sufficiently sigmoid to permit calculation of EC50. 
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Mn-DEPENDENT CELL ADHESION TO THE EIIIA SEGMENT IS SPECIFIC AND MEDIATED VIA A SITE IN THE CENTRAL REGION OF THE SEGMENT
Mn-dependent adhesion to the EIIIA segment by C5.18 and RCJ 3.1 cell lines was specific, since it could be blocked by treatment of EIIIA-coated wells before and during adhesion assays with the anti-EIIIA MAb 15/27, whereas similar treatment of V-coated wells did not inhibit cell adhesion, also measured in the presence of Mn [ Fig. 2 (panel B) ].
CELL ADHESION OCCURS AT LOWER COATING CONCENTRATIONS OF pFN THAN ISOLATED FN SEGMENTS
To further characterize cation-dependent adhesion of C5.18 and RCJ 3.1 cells to isolated III-10, EIIIA and V segments, and to compare these responses to those triggered by a full-length dimeric FN, adhesion was measured in the presence of Ca/Mg or Mn in wells coated with dilution series of specific fusion proteins or rat pFN (Fig. 3 , Table II ). For both cell lines in Ca/Mg, adhesion was evident at lower molar coating concentrations of pFN than of FN segments, with a significantly lower EC50 for pFN in comparison to each of the isolated FN segments that attained sufficient adhesion to derive an EC50 (Table II) . Although such differences were less in Mn, they attained significance for C5.18 adhesion to EIIIA and III-10, and for RCJ 3.1 adhesion to EIIIA (Table II) . The capacity of Mn to stimulate greater cell adhesion than Ca/Mg was also less apparent for pFN than for isolated FN segments (Table II) . For example, dose-response curves for C5.18 adhesion to III-10, EIIIA, and V were shifted to the left in Mn compared to Ca/Mg, whereas the corresponding curves for pFN were essentially superimposable (Fig. 3) . Accordingly, EC50 values for adhesion of either cell line to V and III-10 were significantly reduced in Mn compared to Ca/Mg, whereas values for pFN did not differ significantly (Table II) . Among the four FN segments tested, the stimulatory effect of Mn was greatest for EIIIA, which failed to support adhesion in Ca/Mg (Table II, Fig. 3 ). Although C5.18 cells appeared to adhere to EIIIB-GST in Mn, this signal was nonspecific, since a similar effect was observed for GST (Fig. 3) To determine which integrin subunits are required for C5.18 and RCJ 3.1 recognition of FN segments, MAbs to a1, a2, a5, av, b1, and b3 were tested for their capacities to inhibit cell adhesion. For both lines, Mn-dependent adhesion to EIIIA was inhibited significantly by anti-b1 MAb. MAbs to a2, a5, and av subunits also inhibited adhesion by C5.18 and RCJ 3.1 cells, although these effects attained significance only for the latter cell line (Fig. 4) .
In the presence of Ca/Mg, anti-av and anti-b3 antibodies significantly inhibited adhesion of each cell line to V. Adhesion by C5.18 cells was additionally inhibited by MAbs to a2 and a5 subunits. In contrast, significant inhibition of adhesion to III-10 in Ca/Mg occurred only in response to antia2 for C5.18 cells or anti-a5 for RCJ 3.1 cells (Fig. 4) .
C5.18 AND RCJ 3.1 CELLS RECOGNIZE THE ALTERNATIVELY SPLICED V (BUT NOT EIIIB OR EIIIA) SEGMENT IN THE CONTEXT OF III7-15 PARTIAL FNs
To determine if any of the alternatively spliced segments of FN could be recognized by C5.18 or RCJ 3.1 cells in the context of flanking FN sequences, each cell line was tested for its capacity to adhere to surfaces coated with recombinant III7-15 partial rat FNs carrying one of these segments Fig. 4 . Recognition of the alternatively spliced EIIIA and V segments is integrin dependent. C5.18 (top panels) or RCJ 3.1 (bottom panels) were pre-incubated with anti-integrin MAbs for 30 min and then applied to microtiter wells that had been pre-coated with III-10-GST, V-GST or EIIIA-GST (each at 180 nM) for 2 h in the continued presence of MAb. Results are expressed relative to the number of cells that became adherent to a particular fusion protein in the absence of anti-integrin antibody. Results are averaged for three experiments, each of which was performed using triplicate wells for each condition. (*) P 0.05, (**) P 0.01, (***) P 0.001. To determine whether integrin-mediated recognition of the V segment by C5.18 or RCJ 3.1 cells could be mediated via the ''second'' RGD sequence situated in the V95 subsegment (the C-terminal 95 amino acids of the V segment) of rat FN, cells were incubated with GRGDS or irrelevant glycine-arginine-glycine-glutamic acid-serine (GRGES) peptide (each at 500 mg/ml) before and during cell adhesion assays. Because the V25 subsegment (the N-terminal 25 amino acids) contains an a4 integrin-interactive EILDV Fig. 1 ), III7-15 FNs containing this sequence (''Rþ''), but differing in inclusion of each of the three spliced segments, were tested. One such partial FN contained no alternatively spliced segments (''splice minus'' or ''SM'', thus ''R þ SM''), and the others respectively containing the EIIIB (''R þ Bþ''), EIIIA (''R þ Aþ''), and V (''R þ Vþ'') segments. B. To avoid interfering adhesion signals from the central RGD integrin recognition site in the 10th type III repeat, III7-15 FNs lacking this sequence (''RÀ'') were tested, Dilution series of the RÀ or Rþ III7-15 FNs were coated in microtiter wells and the percent of cells applied that became adherent in the presence of Ca/Mg vs Mn was measured. Results represent three experiments, each performed in triplicate wells for each condition.
sequence, adhesion was also tested in the presence of EILDV peptide. GRGDS inhibited C5.18 and RCJ 3.1 cell adhesion to V-GST (200 nM coating concentration) by 92.4 AE 9.4% and 87.9 AE 6.4% respectively in Ca/Mg (Fig. 6 ), whereas the corresponding values for inhibition of adhesion to III-10-GST were 97.3 AE 3.7% and 96.1 AE 7.0%. In contrast, GRGES and EILDV exerted no significant inhibition of adhesion to V or III-10 by either cell line (Fig. 6) . Pretreatment of wells with anti-V95 rabbit antiserum also significantly inhibited C5.18 cell adhesion (17.7 þ 16.8% of applied cells became adherent, compared to 70.9 þ 4.1% in untreated wells, N ¼ 4, P < 0.01). In contrast, the antiserum did not produce significant inhibition of adhesion to III-10, and preimmune serum had no significant effect upon adhesion to either protein (data not shown). Each of the three R-III7-15 partial FNs lacking the RGD sequence in III-10 in addition to the RGD-containing V segment (R-SM, RÀBþ, and RÀAþ constructs) promoted less adhesion (evident as higher EC50 values) than its Rþ counterpart, whether measured in Ca/Mg or Mn [ Fig. 5, (panels A and B) , and Table III] . Also, in comparison to the Rþ set, RÀ III7-15 constructs generally exhibited larger differences in adhesion-promoting capacity between Ca/Mg vs Mn. For example, while the augmentation in Max%A for adhesion by either cell line in Mn vs Ca/Mg was not significant for any Rþ construct, this difference attained significance for RCJ 3.1 adhesion to R-SM, RÀBþ, and RÀAþ (Fig. 5, Table III) , and for C5.18 adhesion to RÀBþ (Table III) .
Discussion
The RCJ C5.18 (C5.18) nontransformed rat cell line mimics chondrocyte differentiation in vitro 13, 15 and has been used to evaluate the effects of a variety of signaling molecules on this process 14,21e24 . To establish an in vitro system to similarly evaluate effects of FN alternative splicing on chondrocyte differentiation and chondrogenesis, we assessed the capacity of C5.18 cells to recognize the spliced segments of FN. We have found that these cells adhere to (and therefore recognize) the isolated EIIIA and V segments, but do not similarly recognize the EIIIB segment. We also compared the FN recognition capacities of C5.18 cells to those of RCJ 3.1 cells, the multipotential chondroprogenitor line from which C5.18 cells were cloned 25, 26 . Although differences in cation and integrin subunit requirements for adhesion to EIIIA and V segments were apparent, the two lines generally exhibited similar capacities for FN recognition.
In addition to ''inside-out'' activation, which occurs via talin-and kindlen-dependent pathways 27 , integrins can be activated independently of intracellular signaling through interactions of extracellular domain metal-binding sites with Mn 28, 29 . For example, each of the 15 constitutively expressed type III repeats of FN has been observed to support b1 integrin-dependent cell adhesion in the presence of Mn 28 . Like these unspliced repeats, the EIIIA segment was observed in this study to trigger b1 integrin-dependent cell adhesion in Mn but not in Ca/Mg. The relatively weak adhesive activity of this segment raises the possibility that cells could adhere to potent sequences such as the RGD domain in III-10 and V while other segments such as EIIIA may provide instructions that are not strictly adhesive, but might regulate other cell functions, such as gene expression.
Our observation that cell adhesion to the EIIIA segment requires Mn is also reminiscent of the finding that a4b1inte-grin, which does not recognize EIIIA under basal conditions, can be activated by Mn to do so 30 . Furthermore, the absence of C5.18 or RCJ 3.1 cell recognition of the EIIIA segment in the context of surrounding FN sequences is also consistent with previous observations suggesting that cell recognition of this segment is readily ''masked'' by surrounding FN sequences 17 . Finally, both MAb 15/27, raised to a synthetic 29 amino acid peptide from the center of the EIIIA segment 16 , and MAb IST-9 (J. Peters, unpublished results) blocked such adhesion, thus localizing one point of ''B'', ''A'' and ''V'' refer to the alternatively spliced EIIIB, EIIIA and V segments of FN. Dose-response curves were analyzed for: (1) EC50 ¼ the coating concentration at which 50% of maximal cell adhesion was attained, and (2) Max%A ¼ the maximum percentage of cells applied that became adherent. ''À'' indicates that the dose-response curve was not sufficiently sigmoid to permit calculation of EC50.
yP < 0.05 c/w identical construct minus RGD in the 10th type III repeat. zP < 0.01 c/w identical construct minus RGD in the 10th type III repeat. xP < 0.05 c/w RÀVþ. , EILDV, GRGDS þ EILDV, GRGESP þ EILDV, or no peptide, were added to wells in the continued presence of designated peptide and the percent of cells applied that adhered was measured. RGD peptide produced significant inhibition of adhesion by both cell lines to V-GST, III-10-GST, RÀVþ, but not R-SM. The levels of adhesion to RÀVþ in the presence of RGD were less than or equivalent to adhesion to R-SM, suggesting that most if not all of the adhesion-promoting capacity of RÀVþ can be relegated to RGD-inhibitable structures.
recognition of this segment to a central loop structure between C and C 0 beta strands that is of recognized by a4 and a9 integrins in human systems 17, 30, 31 . Unlike the EIIIA segment, adhesion of both cell lines to the V segment occurred in either Ca/Mg or Mn, and was dependent upon av and b3 subunits with an apparent contribution of a5 and a2 subunits to recognition by C5.18 cells. Each line also readily recognized V either in isolation or in the context of a III7-15 partial FN, and such recognition was RGD-dependent. An anti-V95 segment antibody also specifically inhibited C5.18 cell adhesion to V, further localizing a site for recognition by these cells in Ca/Mg to the ''second'' RGD sequence that is situated in the V95 subsegment of rat (but not human) FN.
ELISAs with tag-specific antibodies revealed that the EC50 for RÀVþ was lower than for the other RÀ constructs, attaining significance in the anti-GST ELISA. It is therefore possible that an increased coating efficiency could have contributed to the leftward shift of the cell adhesion dose-response curve for this construct relative to the other RÀ constructs. However, the ELISA data also shows that the average OD for this construct was lower than for R-SM at a 200 nM coating concentration, indicating that a disparity in surface adsorbance between R-SM and RÀVþ constructs does not account for the results of the experiments shown in Fig. 6 , which were performed at a 200 nM coating concentration. These experiments, which show significant preferential cell adhesion to RÀVþ, confirm that both cell lines recognize V in the context of a III7-15 partial FN.
Based upon differential inhibition of cell adhesion by antiintegrin MAbs, the RGD sequences in V and III-10 appear to be recognized by different integrin receptor sets. Also, similar to the RGD sequence in III-10, recognition of which is facilitated by a synergy site in III-9 7 , cellular recognition of RGD in the V segment appears to be enhanced by site(s) external to the segment. This effect, evident as significantly lower EC50 values for C5.18 and RCJ 3.1 adhesion in Ca/Mg to III7-15 RÀVþ (20.6 AE 10.6 and 15.1 AE 10.3 nM, respectively) compared to V-GST (169.2 AE 15.8 and 199.5 AE 114.1 nM) (P < 0.001 for C5.18 and <0.01 for RCJ 3.1), did not appear to result from recognition of constitutively expressed sequences in the RÀVþ construct since, as shown in Fig. 6 , V-GST promoted greater adhesion than the R-SM III7-15 construct at equal molar coating concentrations. Of note, we could not find evidence that recognition of the RGD sequence in III-10 is affected by inclusion of any spliced segment in a III7-15 FN.
Included among the strengths of this study is that we have used direct assays of cell adhesion to unambiguously measure recognition of specific FN segments and isoforms. Included among the limitations is that we have used antibody-blocking to identify FN-interactive integrin subunits. This indirect method has left some unanswered questions, including why anti-b1 MAb failed to block cell adhesion to III-10 or V, despite the capacity of MAbs to a2 and a5 (b1 sub-family a subunits) to do so. Although this could be due to a relatively weaker function-blocking capacity of anti-b1 in comparison to anti-a subunit MAbs, a future goal will be to corroborate these indirect observations through direct isolation and identification of participating integrins on their FN segment ligands.
In summary, we have observed that C5.18 chondrocytic cells recognize the ''cartilage-restricted'' EIIIA and V segments of FN, and we have characterized the specific cation, integrin, and molecular context requirements for such recognition. We have also characterized FN recognition by the RCJ 3.1 cell line, thus facilitating its use as a model to test the effects of FN splicing on a multipotent mesenchymal cell prior to chondrocyte-restriction. These findings should facilitate the use of cell-based systems for analysis of the effects if FN splicing on the chondrocyte differentiation process in vitro.
